about
Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes.Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations.Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.Artificial selection for whole animal low intrinsic aerobic capacity co-segregates with hypoxia-induced cardiac pump failure.Nkx2.5 marks angioblasts that contribute to hemogenic endothelium of the endocardium and dorsal aorta.Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strainsMethods for assessing the electromechanical integration of human pluripotent stem cell-derived cardiomyocyte grafts.Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells.Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettesStatistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal developmentpH-responsive titratable inotropic performance of histidine-modified cardiac troponin I.Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.Zinc finger nucleases: looking toward translation.The developmental origins and lineage contributions of endocardial endothelium.Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells.Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis.Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy.A transcribed enhancer dictates mesendoderm specification in pluripotency.Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.Single-Cell Transcriptomic Analysis of Cardiac Differentiation from Human PSCs Reveals HOPX-Dependent Cardiomyocyte MaturationReprogramming the injured heartEvidence for Minimal Cardiogenic Potential of Stem Cell Antigen 1-Positive Cells in the Adult Mouse HeartProliferation at the heart of preadolescenceSingle-cell RNA-seq of human induced pluripotent stem cells reveals cellular heterogeneity and cell state transitions between subpopulationsGenetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart
P50
Q27345392-017117E9-EC7A-4679-A20B-91D2A179149AQ30498065-A961C9D4-405C-4BCC-BD28-AB1B64143268Q30524974-E38A1C13-7068-4E2A-821D-CDCF9C1A635EQ33476862-89FB41D2-9F5F-4120-9905-C8D893E3969FQ33591207-4DC39162-CA4E-4B79-B1FF-69B71EFC53FCQ34133412-1DD83572-DE9B-48DF-B8A4-2CA91956C7E1Q34214799-B28AC8B3-883F-45E8-AD95-8B72B7D82575Q34285995-895AF5D7-C779-4FD4-916F-EDE500314075Q34447692-5A1B1433-4265-4488-B97A-33067D33B0E9Q35610956-7FFD090B-10EF-4D2F-A269-B3455B9FE654Q35863369-7CB4FB0B-82EA-4A89-ADC1-68B0EC96FC6FQ35866813-110A7F75-906C-44CA-AFC7-427BE014FF9BQ36938437-A6D25138-1A15-4640-AB32-C1290B17B7C4Q37643467-40678532-C2E7-4D49-95A0-30798BEAD5E4Q37982615-5E00C4D3-2446-4169-86D7-887D66645543Q38717460-0854405D-94B8-41FD-A01B-0F704F463005Q38728131-5D6DB8C7-C334-432B-90C9-C4203A09BB75Q41559939-26696F92-9D8D-4091-B6A3-3941E0BD1A11Q46247412-21CBE500-5CE8-48B1-B3FD-BFFADF964DC2Q46976235-D8F58ABF-33B5-45FE-A2A8-8C95F4C36466Q47113021-4D80D664-A540-4328-853D-809028BCF83DQ52430407-0A19B185-24D1-4238-A76F-641EEC4C3369Q57025426-A074CE1A-91A7-46C4-BE5C-3F51E8F30127Q59053758-96CED08D-1139-447D-A682-F960ECAFC9E7Q60301581-05D77755-D6B9-43EC-807D-8D1BFF055D79Q87844621-9C5C3467-B9A6-4CEE-B839-905C6284999FQ88645537-47CC81C7-9D21-43E5-9496-446C0F0A8F12Q89506727-90C38549-F2E6-4888-BD13-51DA0E74101F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nathan J Palpant
@ast
Nathan J Palpant
@en
Nathan J Palpant
@es
Nathan J Palpant
@nl
type
label
Nathan J Palpant
@ast
Nathan J Palpant
@en
Nathan J Palpant
@es
Nathan J Palpant
@nl
prefLabel
Nathan J Palpant
@ast
Nathan J Palpant
@en
Nathan J Palpant
@es
Nathan J Palpant
@nl
P106
P1153
19934254600
P31
P496
0000-0002-9334-8107